Cancer immunotherapy | The PD-L1 pathway
3:21
PD-L1/PD-1 pathway: a security checkpoint
2:50
How do ALK-inhibitors work in ALK-positive lung cancer?
5:11
Unleashing the T-cell army | Cancer immunotherapy at Roche
3:00
Drawn to Science | T-cell bispecific antibodies
18:31
Moving Science Podcast: Episode 4. Part 1/2
2:34
Freiwilligenarbeit in Cham
19:36
Moving Science Podcast: What is the clinical value of Neurofilament light (NfL) in MS Care today?
25:12